Basal Ganglia Circuitry & Clinical Correlates

The basal ganglia are a set of deep subcortical grey-matter nuclei that act as the brain's "movement gatekeeper" — scaling, selecting and smoothing voluntary motor programmes. For NEET PG this topic is a goldmine because the circuit logic (direct vs indirect pathway) maps directly onto classic movement disorders: Parkinson's disease, Huntington's chorea and hemiballismus. Master the wiring once and the clinical questions answer themselves.

Components & terminology

The basal ganglia are not a single structure but a functionally linked group. The naming is a favourite exam trap, so anchor it firmly.

Term	Structures included
Corpus striatum	Caudate + Putamen + Globus pallidus (whole)
Striatum (neostriatum)	Caudate nucleus + Putamen
Lentiform (lenticular) nucleus	Putamen + Globus pallidus (GPe + GPi)
Paleostriatum	Globus pallidus
Archistriatum	Amygdala

The functional (motor-relevant) basal ganglia comprise five nuclei:

1. Striatum — caudate + putamen (the main input station)
2. Globus pallidus externa (GPe) — relay in the indirect loop
3. Globus pallidus interna (GPi) — major output station
4. Subthalamic nucleus (STN) — drives the indirect pathway, the only excitatory intrinsic nucleus
5. Substantia nigra — pars compacta (SNc, dopaminergic) + pars reticulata (SNr, an output station functionally twinned with GPi)

High-yield: The input to the basal ganglia is the striatum; the output is via GPi + SNr. Both output via the thalamus (VA/VL nuclei) back to the cortex. The basal ganglia have no direct connection to the spinal cord — they influence movement only through the cortex.

The striatum receives glutamatergic (excitatory) input from virtually the entire cerebral cortex and dopaminergic input from the SNc. Its principal projection neuron is the medium spiny neuron (MSN), which is GABAergic (inhibitory).

Neurotransmitters — the alphabet of the circuit

Knowing the transmitter at each synapse lets you derive net effects rather than memorise them.

Pathway / connection	Transmitter	Net effect
Cortex → Striatum	Glutamate	Excitatory
Striatum → GPi / GPe / SNr	GABA	Inhibitory
GPe → STN	GABA	Inhibitory
STN → GPi / SNr	Glutamate	Excitatory
GPi / SNr → Thalamus	GABA	Inhibitory (tonic)
Thalamus → Cortex	Glutamate	Excitatory
SNc → Striatum	Dopamine	D1 excitatory, D2 inhibitory

High-yield: STN is the only intrinsic basal ganglia nucleus that is excitatory (glutamatergic). Everything else internal is GABAergic. The output nuclei (GPi/SNr) are tonically active, continuously inhibiting the thalamus — i.e. the resting state is "brake ON."

The direct & indirect pathways

This is the conceptual heart of the topic. The cortex wants to release a movement; the basal ganglia decide whether to lift the brake (direct) or press it harder (indirect).

Direct pathway — FACILITATES movement

Cortex (Glu, +) → Striatum (GABA, –) → GPi/SNr (GABA, –) → Thalamus (Glu, +) → Cortex

Two inhibitory synapses in series produce net disinhibition of the thalamus:

Cortex → excites striatum → inhibits GPi → GPi stops inhibiting thalamus → thalamus excites cortex → movement GO

The striatal MSNs of the direct pathway carry D1 receptors and express substance P + dynorphin. Dopamine (via D1) EXCITES the direct pathway → reinforces movement facilitation.

Indirect pathway — INHIBITS movement

Cortex → Striatum (GABA, –) → GPe (GABA, –) → STN (Glu, +) → GPi/SNr (GABA, –) → Thalamus

Trace the signs through this longer loop:

Striatum inhibits GPe → GPe stops inhibiting STN → STN (now disinhibited) excites GPi → GPi inhibits thalamus more strongly → movement STOP/suppression of unwanted movement

The indirect MSNs carry D2 receptors and express enkephalin. Dopamine (via D2) INHIBITS the indirect pathway → reduces its movement-suppressing effect.

High-yield: Dopamine from SNc has a dual but synergistic action — it excites the direct (D1) and inhibits the indirect (D2) pathway. Both actions promote movement. So dopamine = "pro-movement." Loss of dopamine (Parkinson) = hypokinesia.

The hyperdirect pathway (newer, occasionally asked)

A fast monosynaptic cortex → STN glutamatergic projection that bypasses the striatum, giving a rapid "global stop/brake" before the slower direct/indirect loops fine-tune the choice. It underlies the success of STN deep brain stimulation.

Mnemonic for receptor coupling: "D1 = Direct (1 word, GO)" and "D2 = inDirect (2nd loop, in the way → STOP)." Substance P travels the direct path (P for "Push the movement"); Enkephalin travels the indirect.

Functional loops (anatomical organisation)

The basal ganglia run several parallel cortico–striato–thalamo–cortical loops, all asked occasionally:

• Motor loop — putamen-centred (supplementary motor area). Movement scaling.
• Oculomotor loop — caudate body → frontal/supplementary eye fields. Saccades.
• Prefrontal (associative) loop — caudate head → dorsolateral prefrontal cortex. Executive function.
• Limbic loop — ventral striatum (nucleus accumbens) → anterior cingulate/orbitofrontal. Motivation, reward, addiction, OCD.

High-yield: The putamen is the chief motor territory; the caudate is largely cognitive/oculomotor; the nucleus accumbens (ventral striatum) is the reward/limbic hub (dopamine, addiction).

Blood supply (anatomy questions love this)

• Striatum & internal capsule: lateral striate (lenticulostriate) branches of the middle cerebral artery — the classic "arteries of cerebral haemorrhage / Charcot."
• Head of caudate & anterior limb: medial striate artery of Heubner (recurrent artery of Heubner, from ACA/anterior communicating).
• Globus pallidus: anterior choroidal artery.

High-yield: Bilateral globus pallidus necrosis is classic for carbon monoxide poisoning; also seen in hypoxia, methanol and cyanide. T2/FLAIR shows symmetrical pallidal hyperintensity.

Clinical correlates — the disorders

Movement disorders divide neatly into hypokinetic (too little movement → direct-pathway underactive / indirect overactive) and hyperkinetic (too much → indirect underactive).

Parkinson's disease (hypokinetic)

• Lesion: degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc) → loss of striatal dopamine.
• Circuit effect: less D1 drive (direct underactive) + less D2 inhibition (indirect overactive) → GPi overactive → thalamus over-inhibited → cortex under-driven → hypokinesia.
• Pathology: Lewy bodies — eosinophilic cytoplasmic inclusions of α-synuclein (also ubiquitin-positive).
• Cardinal features (TRAP): Tremor (resting, 4–6 Hz, "pill-rolling"), Rigidity (cogwheel/lead-pipe), Akinesia/bradykinesia, Postural instability. Mask-like facies, festinant shuffling gait, micrographia, stooped posture.
• Drug of choice: Levodopa + carbidopa (carbidopa = peripheral dopa-decarboxylase inhibitor, reduces peripheral side effects, does not cross BBB). Others: dopamine agonists (pramipexole, ropinirole), MAO-B inhibitors (selegiline, rasagiline), COMT inhibitors (entacapone), amantadine, anticholinergics (for tremor in the young).

High-yield: Resting tremor that decreases with voluntary movement = Parkinson; intention tremor that worsens on approaching a target = cerebellar. Don't confuse them.

Huntington's disease (hyperkinetic — chorea)

• Lesion: loss of GABAergic MSNs of the striatum (caudate first); the indirect pathway is preferentially lost early.
• Circuit effect: indirect path damaged → STN/GPi under-driven → thalamus disinhibited → excess, unwanted movement (chorea).
• Genetics: autosomal dominant, CAG trinucleotide repeat expansion in the HTT gene on chromosome 4p16.3; shows anticipation (worsening with successive generations, paternal transmission).
• Features: chorea (irregular, dance-like, non-purposeful movements), progressive dementia, psychiatric changes (depression, suicide). Onset typically 30–50 yrs.
• Imaging: caudate atrophy → "boxcar"/butterfly dilatation of frontal horns of lateral ventricles; loss of the normal convex caudate bulge.
• Drug: Tetrabenazine (VMAT2 inhibitor, depletes dopamine) for chorea; antipsychotics for behaviour.

High-yield: Huntington = caudate atrophy + CAG repeats + chorea + dementia. The neurotransmitter losses are GABA and acetylcholine (in the striatum), with relative dopamine excess — hence dopamine-depleting tetrabenazine helps.

Hemiballismus (hyperkinetic — wild flinging)

• Lesion: subthalamic nucleus (STN), classically a lacunar infarct/haemorrhage in the contralateral STN (hypertensive elderly).
• Circuit effect: STN normally excites GPi (indirect path). Lose STN → GPi under-driven → thalamus disinhibited → violent, large-amplitude flinging (ballistic) movements of the contralateral limbs.
• Classic statement: unilateral STN lesion → contralateral hemiballismus.
• Management: often self-limiting; dopamine blockers (haloperidol), tetrabenazine; rarely surgery.

High-yield: STN lesion → contralateral hemiballismus is one of the most repeated single-line NEET PG facts. The movement is proximal and violent ("ballistic = throwing").

Other named correlates

• Wilson's disease: copper deposition in the lentiform (putamen) nucleus → "face of the giant panda" sign on MRI midbrain, Kayser–Fleischer rings, low ceruloplasmin; treated with penicillamine/zinc/trientine.
• Sydenham's chorea: post-streptococcal (rheumatic fever), autoimmune anti-basal-ganglia antibodies; a major Jones criterion.
• Athetosis (slow, writhing) and dystonia (sustained co-contraction) localise broadly to the striatum/putamen; kernicterus damages globus pallidus → choreoathetoid cerebral palsy.
• Tardive dyskinesia: chronic D2 blockade → receptor upregulation/supersensitivity.

Diagnosis & investigations of choice

Condition	Investigation of choice / key finding
Parkinson's disease	Primarily clinical; DaTscan (¹²³I-FP-CIT SPECT) shows reduced striatal dopamine transporter uptake; good levodopa response supports diagnosis
Huntington's disease	Genetic testing for CAG repeats (≥36–40 abnormal); MRI caudate atrophy
Hemiballismus	MRI/CT brain — contralateral STN infarct/bleed
Wilson's disease	Serum ceruloplasmin ↓, 24-h urinary copper ↑, slit-lamp KF rings, MRI panda sign
CO poisoning	Bilateral globus pallidus T2 hyperintensity; carboxyhaemoglobin level

Summary of circuit dysfunction

Hypokinetic disorders (Parkinson) → GPi/SNr OVERACTIVE → thalamus excessively inhibited → too little movement. Hyperkinetic disorders (Huntington chorea, hemiballismus) → GPi/SNr UNDERACTIVE → thalamus disinhibited → too much movement.

This single sentence is the master key — derive any disorder's phenomenology from whether the final output (GPi) is over- or under-driven.

Key differentials

• Resting vs intention tremor: basal ganglia (Parkinson) vs cerebellar.
• Chorea causes: Huntington, Sydenham, SLE/antiphospholipid, chorea gravidarum, drug-induced (levodopa, OCPs), Wilson.
• Parkinsonism mimics ("Parkinson-plus"): progressive supranuclear palsy (vertical gaze palsy, falls), multiple system atrophy (autonomic failure), corticobasal degeneration, drug-induced parkinsonism (antipsychotics, metoclopramide) — these respond poorly to levodopa, unlike idiopathic PD.
• Wilson vs Huntington: both young-ish with movement + psychiatric features; check copper studies and KF rings.

Recently asked / exam angle

• "Excitatory nucleus of basal ganglia" → Subthalamic nucleus (STN) (glutamatergic).
• "Lesion causing hemiballismus" → contralateral STN.
• "Direct pathway neurotransmitter / receptor" → substance P + dynorphin, D1 (dopamine excites); indirect → enkephalin, D2 (dopamine inhibits).
• "Lewy body composition" → α-synuclein.
• "Earliest structure affected in Huntington" → caudate nucleus (indirect pathway MSNs).
• "Carbidopa mechanism" → peripheral dopa-decarboxylase inhibitor, doesn't cross BBB.
• "Lentiform nucleus = ?" → putamen + globus pallidus.
• "Boxcar ventricles / butterfly frontal horns" → Huntington's disease.
• "Panda sign / KF ring" → Wilson's disease.
• "Bilateral globus pallidus necrosis" → carbon monoxide poisoning.
• Net effect questions: "Stimulation of direct pathway does what to movement?" → facilitates (disinhibits thalamus).

Rapid revision

1. Striatum = input (caudate + putamen); GPi + SNr = output; both relay via thalamus (VA/VL) back to cortex.
2. STN is the only excitatory (glutamatergic) intrinsic nucleus; all other internal projections are GABAergic.
3. Direct pathway facilitates movement via D1 (dopamine excites; substance P/dynorphin); two GABA synapses → net thalamic disinhibition.
4. Indirect pathway inhibits movement via D2 (dopamine inhibits; enkephalin); routes through GPe → STN.
5. Dopamine is pro-movement — excites direct, inhibits indirect; SNc loss = Parkinson's hypokinesia.
6. Parkinson = SNc degeneration, Lewy bodies (α-synuclein), TRAP, DOC levodopa–carbidopa.
7. Huntington = AD, CAG repeats (chr 4), caudate atrophy, chorea + dementia, anticipation, DOC tetrabenazine.
8. Hemiballismus = contralateral STN lesion, violent proximal flinging.
9. Lentiform = putamen + globus pallidus; corpus striatum = striatum + globus pallidus.
10. Hypokinetic = GPi overactive; hyperkinetic = GPi underactive — the master rule.
11. Wilson = lentiform (putamen) copper, panda sign, KF rings, low ceruloplasmin.
12. Basal ganglia have no direct spinal output — they act entirely through the cortex.